SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Activity

26 hedge funds and large institutions have $697K invested in Salarius Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$339K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$57K
3
Citadel Advisors
3
Citadel Advisors
Florida
$20K
4
PAM
4
Panagora Asset Management
Massachusetts
$29K
5
UBS Group
5
UBS Group
Switzerland
$13K

Top Sellers

1
Deutsche Bank
1
Deutsche Bank
Germany
$0
2
Primecap Management
2
Primecap Management
California
$13K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$39K
4
WS
4
Wedbush Securities
California
$0
5
TI
5
Telemetry Investments
New York
$5K
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
26
Simplex Trading
Illinois
– – -100 Closed
Barclays
27
Barclays
United Kingdom
$0 88 – –
LTFS
28
Ladenburg Thalmann Financial Services
Florida
$0 100 – –
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$0 342 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
Fidelity Investments
31
Fidelity Investments
Massachusetts
$0 277 – –
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$0 276 +250 +962%
1
2